Trending...
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
Strategic agreement expands bioprocessing equipment (SFC systems) availability to the Pharma industry across Europe after Novasep exited the technology years ago.
PITTSBURGH - Marylandian -- Thar Process, a leader in supercritical CO2 extraction and purification technology (SFE and SFC), today announced a partnership with ExtrateX, a premier French specialist in supercritical fluid systems, to represent and distribute its advanced SFC systems throughout Europe. This provides clients with comprehensive sales and technical support in pharmaceutical, biotech, and specialty chemical labs across the region.
"We are excited to re-enter Europe with our SFC systems," said Todd Palcic, CEO of Thar Process. "SFC is a platform technology that utilizes upcycled CO2 for purification of natural and synthetic molecules that is both highly efficient and sustainable at the same time. ExtrateX's deep expertise in supercritical CO2 systems and strong presence across Europe make them the ideal partner."
Thar Process's Isolator™ SFC systems are designed for high-resolution separation and purification bioprocessing applications, including pharmaceutical APIs and excipients, fermented products, peptides (GLP-1s, etc.) and natural products like omega-3s and cannabinoids. The technology offers advantages in speed, efficiency, and environmental sustainability compared to conventional separation methods.
More on Marylandian
"We are excited to partner with Thar Process and to bring some of the most advanced SFC systems to the European market," said Gonzague Choppe, CEO of ExtrateX. "This strategic collaboration brings together the complementary strengths of two companies with extensive expertise in supercritical fluid technologies. Thar Process brings some of the most advanced SFC solutions and deep chromatography expertise, while ExtrateX contributes its extensive experience in supercritical fluid technologies, process expertise, scale-up capabilities and strong European presence."
The partnership becomes effective on the first day of 2027, with ExtrateX establishing sales and support operations to serve European customers. The company will handle equipment sales, technical installation, maintenance, and customer training.
About Thar Process
Based in Pittsburgh, Pennsylvania, Thar Process is a leading developer and operator of supercritical fluid extraction and purification systems. With deep expertise spanning laboratory R&D, contract processing, and equipment development, Thar Process serves the pharmaceutical, biotech, specialty chemical, and industrial sectors with innovative supercritical fluid chromatography (SFC) and extraction solutions designed for efficiency, sustainability, and superior results. https://www.TharProcess.com
More on Marylandian
About ExtrateX
EXTRATEX is a France-based leader in supercritical fluid technology, delivering advanced equipment and process solutions for applications ranging from R&D and process development to pilot and industrial scale. Drawing on extensive expertise in supercritical fluid processes and equipment engineering, EXTRATEX serves leading companies across the food, nutraceutical, pharmaceutical, cosmetic and fragrance industries. With a growing installed base and a strong technical support network across Europe, EXTRATEX is a trusted technology partner for the development, scale-up and implementation of innovative supercritical processes. https://www.extraxtex-sfi.com
"We are excited to re-enter Europe with our SFC systems," said Todd Palcic, CEO of Thar Process. "SFC is a platform technology that utilizes upcycled CO2 for purification of natural and synthetic molecules that is both highly efficient and sustainable at the same time. ExtrateX's deep expertise in supercritical CO2 systems and strong presence across Europe make them the ideal partner."
Thar Process's Isolator™ SFC systems are designed for high-resolution separation and purification bioprocessing applications, including pharmaceutical APIs and excipients, fermented products, peptides (GLP-1s, etc.) and natural products like omega-3s and cannabinoids. The technology offers advantages in speed, efficiency, and environmental sustainability compared to conventional separation methods.
More on Marylandian
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
- LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
"We are excited to partner with Thar Process and to bring some of the most advanced SFC systems to the European market," said Gonzague Choppe, CEO of ExtrateX. "This strategic collaboration brings together the complementary strengths of two companies with extensive expertise in supercritical fluid technologies. Thar Process brings some of the most advanced SFC solutions and deep chromatography expertise, while ExtrateX contributes its extensive experience in supercritical fluid technologies, process expertise, scale-up capabilities and strong European presence."
The partnership becomes effective on the first day of 2027, with ExtrateX establishing sales and support operations to serve European customers. The company will handle equipment sales, technical installation, maintenance, and customer training.
About Thar Process
Based in Pittsburgh, Pennsylvania, Thar Process is a leading developer and operator of supercritical fluid extraction and purification systems. With deep expertise spanning laboratory R&D, contract processing, and equipment development, Thar Process serves the pharmaceutical, biotech, specialty chemical, and industrial sectors with innovative supercritical fluid chromatography (SFC) and extraction solutions designed for efficiency, sustainability, and superior results. https://www.TharProcess.com
More on Marylandian
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
About ExtrateX
EXTRATEX is a France-based leader in supercritical fluid technology, delivering advanced equipment and process solutions for applications ranging from R&D and process development to pilot and industrial scale. Drawing on extensive expertise in supercritical fluid processes and equipment engineering, EXTRATEX serves leading companies across the food, nutraceutical, pharmaceutical, cosmetic and fragrance industries. With a growing installed base and a strong technical support network across Europe, EXTRATEX is a trusted technology partner for the development, scale-up and implementation of innovative supercritical processes. https://www.extraxtex-sfi.com
Source: Thar Process LLC
0 Comments
Latest on Marylandian
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- HIRO Ostomy Belt Launch by Richard O'Hamill
- Ivyctory CEO Delivers Special Talk at InnoPharm 2026, Meets Drug Discovery Online Leadership
- From Advocacy to Action: Ivyctory Solutions Reflects on Two Years of Progress Since Falling Walls
- SpearPoint Ink Launches Two New Services to Help Business Experts Attract More Qualified Clients
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Coming Up on Bloomberg: Kim Natovitz Puts Long-Term Care Planning in the National Spotlight
- Whose Ashes Are These? RetURN.org Launches Permanent IDs for Human and Pet Urns
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc

